These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 27507113)

  • 1. Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.
    Hanberg JS; Rao V; Ter Maaten JM; Laur O; Brisco MA; Perry Wilson F; Grodin JL; Assefa M; Samuel Broughton J; Planavsky NJ; Ahmad T; Bellumkonda L; Tang WH; Parikh CR; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure.
    Ter Maaten JM; Damman K; Hanberg JS; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; Cleland JG; Bloomfield DM; Hillege HL; van Veldhuisen DJ; Voors AA; Testani JM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function.
    Kitai T; Grodin JL; Kim YH; Tang WH
    Circ Heart Fail; 2017 Feb; 10(2):e003603. PubMed ID: 28130379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR.
    Ikeda Y; Inomata T; Kida K; Shibagaki Y; Sato N; Izumi T; Ako J;
    Heart Vessels; 2019 Mar; 34(3):442-451. PubMed ID: 30259172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial direct sodium removal in patients with heart failure and diuretic resistance.
    Rao VS; Ivey-Miranda JB; Cox ZL; Moreno-Villagomez J; Ramos-Mastache D; Neville D; Balkcom N; Asher JL; Bellumkonda L; Bigvava T; Shaburishvili T; Bartunek J; Wilson FP; Finkelstein F; Maulion C; Turner JM; Testani JM
    Eur J Heart Fail; 2024 May; 26(5):1215-1230. PubMed ID: 38556717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
    Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Chloride and the Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload: A Post Hoc Analysis From the ADVOR Trial.
    Van den Eynde J; Martens P; Dauw J; Nijst P; Meekers E; Ter Maaten JM; Damman K; Filippatos G; Lassus J; Mebazaa A; Ruschitzka F; Dupont M; Mullens W; Verbrugge FH
    Circ Heart Fail; 2024 Oct; 17(10):e011749. PubMed ID: 39171394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
    J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
    Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
    Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
    Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
    Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-23 (Fibroblast Growth Factor-23) and Cardiorenal Interactions.
    Ivey-Miranda JB; Stewart B; Cox ZL; McCallum W; Maulion C; Gleason O; Meegan G; Amatruda JG; Moreno-Villagomez J; Mahoney D; Turner JM; Wilson FP; Estrella MM; Shlipak MG; Rao VS; Testani JM
    Circ Heart Fail; 2021 Nov; 14(11):e008385. PubMed ID: 34689571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
    Fukui M; Tsujino T; Hirotani S; Ito H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Kawabata M; Masuyama T
    Heart Vessels; 2017 Jul; 32(7):865-871. PubMed ID: 28105515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazide diuretics versus loop diuretics in stage 3-5 CKD: impact on cardiorenal outcomes.
    Sung LC; Chiu HW; Yu SM; Tsou LL; Hsu YH; Wu MS; Lin CL; Tsai FJ; Chou CL
    Postgrad Med; 2024 Sep; 136(7):738-748. PubMed ID: 39189768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on diuretic resistance in chronic congestive heart failure.
    Shah N; Madanieh R; Alkan M; Dogar MU; Kosmas CE; Vittorio TJ
    Ther Adv Cardiovasc Dis; 2017 Oct; 11(10):271-278. PubMed ID: 28728476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
    Miyata M; Sasaki T; Ikeda Y; Shinsato T; Kubozono T; Furusho Y; Kusumoto A; Hamasaki S; Tei C;
    J Cardiol; 2012 May; 59(3):352-8. PubMed ID: 22365947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
    Verbrugge FH; Martens P; Boonen L; Nijst P; Verhaert D; Noyens P; De Vusser P; Dupont M; Tang WHW; Mullens W
    Acta Cardiol; 2018 Aug; 73(4):335-341. PubMed ID: 28971753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
    Tominaga N; Kida K; Inomata T; Sato N; Izumi T; Akashi YJ; Shibagaki Y
    Am J Nephrol; 2017; 46(5):417-426. PubMed ID: 29130954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.